Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8229493.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twenty-two premature infants with chronic lung disease (median gestational age 28 weeks) received polyribosylribitol phosphate-outer membrane protein conjugate Haemophilus vaccine at 2 and 4 months of chronologic age. The proportions with antibodies to polyribosylribitol phosphate at levels > 1 microgram/ml after doses 1 and 2 were 27% and 55%; geometric mean titers were 0.43 and 0.73 microgram/ml, significantly lower than values for term infants.
Medical subject headings
- Bacterial Outer Membrane Proteins
- Haemophilus Vaccines
- Infant, Premature, Diseases
- Lung Diseases
- Polysaccharides, Bacterial
- Vaccines, Synthetic